SCHEMBL14919644

SCHEMBL14919644

CC(NP(=O)(Oc1ccc([N+](=O)[O-])cc1)Oc1cccc2ccccc12)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ ALOX5 P09917 2/20 0.42
▸ PTGES O14684 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CES2 O00748 1/20 0.40
▸ CES1 P23141 1/20 0.40
▸ ANO1 Q5XXA6 1/20 0.39
▸ ANO2 Q9NQ90 1/20 0.39
▸ FFAR1 O14842 1/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18444223 1.00 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL14921393 1.00 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL18444225 1.00 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL14921296 1.00 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL18444222 1.00 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL30511498 0.91 ALOX5 (0.41) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL17550484 0.89 BTN3A1 (0.40) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL30583779 0.88 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL16258629 0.88 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1
SCHEMBL16258631 0.88 MEN1 (0.42) MEN1KMT2AALOX5PTGESALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776438-A1 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHORAMIDATE AND PHOSPHORDIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS Inhibitex, Inc. (US) 2014-09-17 — — EP disclosed
WO-2013070887-A1 SUBSTITUTED PURINE NUCLEOSIDES, PHOSPHORAMIDATE AND PHOSPHORDIAMIDATE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS INHIBITEX, INC. (US) 2013-05-16 — — WO disclosed
WO-2013066991-A1 CRYSTALLINE SOLVATES OF NUCLEOSIDE PHOSPHOROAMIDATES, THEIR STEREOSELECTIVE PREPARATION, NOVEL INTERMEDIATES THEREOF, AND THEIR USE IN THE TREATMENT OF VIRAL DISEASE INHIBITEX, INC. (US) 2013-05-10 — — WO disclosed
Send feedback